bioAffinity Technologies, Inc. (BIAFW) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Diagnostics & Research 산업에서 운영. 본사 소재지는 San Antonio, DE, 미국. 현재 CEO는 Maria Zannes.
BIAFW 을(를) 보유 57 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $1.62M.
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
